Business
SKAN with significant profit increase and strong order intake in the 2024 financial year
SKAN with significant profit increase and strong order intake in the 2024 financial
About this update from Skan Group Ag
[{"type":"text","content":"\nSKAN AG / Key word(s): Annual Results\n\nSKAN with significant profit increase and strong order intake in the 2024 financial year \n25-March-2025 / 06:00 CET/CEST\n\nRelease of an ad hoc announcement pursuant to Art. 53 LR\n\nThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRSKAN with significant profit increase and strong order intake in the 2024 financial yearOrder intake increased by 21.8% to CHF 359.5 million; order backlog of CHF 318.3 million gives good visibility for the rest of the year.Net sales up by 12.9% to CHF 361.3 million; adjusted for currency effects, growth was 13.6%.EBITDA improved by 13.6% to CHF 57.0 million; EBITDA margin reaches 15.8%.Dividend of CHF 0.40 per share proposed for the 2024 financial year.Strategic initiatives for integrated process systems and a higher degree of standardization in the equipment business are on track; pre-approved services to start in 2026.For 2025, a revenue growth in the mid-teens and an EBITDA margin between 14 and 16% are targeted.\nAllschwil, 25 March 2025 – The SKAN Group can report another successful financial year. Market growth continued unabated in 2024. The ongoing trend towards injectable drugs, and thus towards SKAN’s process solutions for the aseptic filling of biopharmaceutical active ingredients, ensured high demand among customers. In the reporting year, there was particularly strong demand for filling lines for antibody drug conjugates (ADCs) – modern oncology drugs that enable more targeted therapies. SKAN received several orders in the double-digit million range for such large and complex lines with the highest quality requirements. Another, albeit less pronounced, driver was equipment for filling GLP-1 drugs for obesity, which accounted for around 15% of the order intake in the reporting year. Last but not least, the logjam of orders that occurred after the coronavirus boom has now been cleared.\n\nTaken together, these factors contributed to a marked increase in incoming orders compared to the previous year. In particular, a significant increase in requests for quotations was noticeable from May onwards, reflected in an acceleration of incoming orders towards the end of 2024. The success rate for quotations remained high, which is attributable to the high quality and leading technology of SKA...